
Osborne Clarke is experienced in advising start-ups on investments via large-volume financing rounds and routinely acts across the pharmaceutical, fintech, energy and technology sectors; the team is also well versed in supporting leading European start-ups from the AI segment. The venture capital practice acts integrated into the corporate group and is led by Nicolas Gabrysch, who focuses on growth financing in the venture and growth capital areas, primarily in the US. Robin Eyben mainly advises clients from the technology sector as well as transformation-driven investors, funds and start-ups on the entire VC value chain.
Testimonials
Collated independently by Legal 500 research team.
'Very well-positioned team, which covers various relevant areas and reacts quickly and precisely. Particularly strong and competent in negotiations with third parties, e.g. investors, comprehensive know-how ensures good solutions for difficult financing issues.'
'Till-Manuel Saur is a really pleasant person who has excellent technical expertise and negotiating skills. He always has a solution and was flexible in responding to our requests. A great negotiator who knows how to convince people with his calm, level-headed manner.'
'OC has a dedicated team of venture capital specialists who are familiar with (simple or complicated) deals.'
'Till-Manuel Saur is a very strong advisor.'
'Very experienced team, high visibility in the market, good benchmarks due to high number of transactions.'
Key clients
- Aleph Alpha
- Endeit Fund III
- Force over Mass
- FundaMental Pharma GmbH
- G2 Venture Partners
- GovRadar GmbH
- Index Ventures
- Instagrid
- neoteq venture Rheinland One GmbH & Co. KG
- Nosh.bio GmbH
- Redstone
- Rydes
- Segenia Capital
- Smart Reporting
- VR Ventures
- Warburg Pincus
- Hollyport Capital
Lawyers
